Company: AEMD
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001683168-25-002685
Chunk: 2

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 2
---
 further
information, please see the Questions and Answers about the Special Meeting beginning on the first page of the accompanying Proxy Statement.

The Special Meeting will be held for the following
purposes:

| 1. | To approve, pursuant to Nevada Revised Statutes 78.2055, a reverse stock split of our common stock at a ratio in the range of 1-for-5 to 1-for-12, with such ratio to be determined in the discretion of our Board of Directors and with such reverse stock split to be effected at such time and date as determined by our Board of Directors in its sole discretion (but in no event later than May 13, 2026) (Proposal No. 1); and |
|:---|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2. | To approve the issuance of shares of common stock upon exercise of the warrants to purchase common stock (the “Inducement Warrants”) issued in a private placement, and to approve the Reset of Exercise Price provision contained in the Inducement Warrants (Proposal No. 2);                                                                                                                                                       |
| 3. | To approve the adjournment of the Special Meeting to another place, or a later date or dates, if necessary or appropriate, to solicit additional proxies in the event we have not received sufficient votes in favor of any of the foregoing proposals (Proposal No. 3); and                                                                                                                                                          |
| 4. | To transact such other business as may properly come before the Special Meeting or any adjournment or postponement thereof.                                                                                                                                                                                                                                                                                                           |

We have fully set forth the proposals and information
relevant thereto in the accompanying Proxy Statement, which you are urged to read thoroughly. For the reasons set forth in the Proxy Statement,
our Board of Directors recommends “FOR” each of Proposals 1, 2 and 3. Action may be taken on any one of the foregoing proposals
at the Special Meeting on the date specified above or on any date or dates to which the meeting may be postponed or adjourned. We do not
expect to transact any other business at the Special Meeting.

Stockholders of record at the close of business on
March 27, 2025 will be entitled to notice of and to vote at the Special Meeting and at any continuation or adjournment thereof. A list
of the stockholders of record as of the close of business on March 27, 2025 will be available for inspection by any of our stockholders
for